Nov 16, 2026 · 12 min read
How to Document a Diabetic Foot Exam (With a Template)
Documentation Templates Progress notes
A good diabetic foot exam note lets the next clinician see what you tested, what you found on each foot, what risk category that puts the person in and when they're due back, without having to repeat the exam. This guide to documenting a diabetic foot exam follows the International Working Group on the Diabetic Foot (IWGDF) 2023 guidelines. It works for podiatrists, primary care clinicians and nurses doing annual screens, and it ends with two example notes and a template you can copy.
This is about what to record, not a clinical protocol. Follow your local guideline and your employer's policy, and check the current versions: guidelines are revised every few years, and the ones below differ on risk categories and review intervals.
What a diabetic foot exam record needs to show
Every screen, whatever the template, should record:
- History: previous ulcer or amputation, kidney disease, vascular history, symptoms, smoking.
- Inspection of both feet: skin, nails, callus, pre-ulcerative signs, deformity.
- Sensation: which test, which sites, and the result for each foot.
- Vascular status: pulses on each foot, plus any further testing.
- Footwear and self-care.
- Risk category, naming the system you used.
- Plan: education given, treatment, referrals and the date of the next review.
The IWGDF asks for a screen for loss of protective sensation (LOPS) and peripheral artery disease (PAD) at least once a year in everyone with diabetes. If either one is present, it asks for a fuller exam at every review, so the "at-risk" fields below matter most for those patients.
Documenting the diabetic foot exam, field by field
1. History
Record yes or no, with dates where you have them:
- Previous foot ulcer (site and date healed)
- Previous lower-limb amputation (level, side)
- End-stage renal disease or dialysis
- Charcot foot
- Angioplasty or vascular surgery
- Retinopathy
- Smoking status
- Symptoms: numbness, tingling, foot pain at rest or when walking, claudication (and the walking distance it starts at)
- Things that affect self-care: vision, mobility, being able to reach their feet, living alone, access to care
The IWGDF singles out end-stage renal disease, which together with LOPS or PAD puts someone in its high-risk category, and suggests asking about social isolation, access to care, financial constraints and frailty.
2. Inspection: skin, nails and deformity
Shoes and socks off, both feet, and note left and right separately. NICE also says to remove bandages and dressings.
- Skin: color, temperature, edema, dryness, fungal infection, hygiene
- Callus: site and how heavy it is
- Pre-ulcerative signs: blisters, fissures, hemorrhage under callus
- Ulcer: present or absent. If present, record site and size, and grade it on your service's wound record
- Nails: thickened, ingrown, poorly cut
- Deformity: claw or hammer toes, hallux valgus, prominent metatarsal heads, Charcot changes, previous amputation
- Joint mobility: limited ankle or first metatarsophalangeal joint movement
A body chart is quicker to read than a paragraph. Mark callus, deformity and any lesions on a foot diagram, and keep the text for what the diagram can't show.
3. Monofilament foot exam and other sensation tests
The 10 g Semmes-Weinstein monofilament is the standard test for LOPS. Record:
- Sites tested on each foot. The IWGDF practical guidelines say to test three sites on each foot and show which sites to choose from in a diagram. Name the sites you used, such as plantar hallux and first and fifth metatarsal heads.
- Result per site, as correct answers out of three. Each site gets two real applications and at least one "mock" application. Sensation is present if the person answers two of three correctly.
- Sites you skipped and why: the IWGDF says not to apply the filament on an ulcer, callus, scar or necrotic tissue.
Then record a second test:
- Vibration: 128 Hz tuning fork on the dorsal distal phalanx of the hallux, scored the same way (two of three correct). If it isn't felt at the toe, the IWGDF says to repeat it more proximally, so record where it was first felt (for example, medial malleolus).
- Ipswich Touch Test if you don't have a monofilament: a light fingertip touch on the tips of the first, third and fifth toes of each foot. LOPS is likely if two or more of the six sites aren't felt.
Guidelines differ here, so record every test you did. The ADA wants the monofilament (or Ipswich Touch Test) plus at least one more test (pinprick, temperature or vibration), and treats an absent monofilament response plus one other abnormal test as confirming LOPS. The IWGDF suggests vibration testing when the monofilament result is normal.
End the section with a one-line conclusion for each foot: "LOPS present" or "LOPS absent."
4. Pulses and vascular findings
- Dorsalis pedis and posterior tibial pulses, each foot: palpable, weak or absent
- Capillary refill, skin temperature and color if relevant
- Claudication or rest pain (from the history)
- Further tests if pulses are absent or PAD is suspected: Doppler waveforms, ankle-brachial index (ABI), toe pressures and toe-brachial index (TBI), with the values
NICE warns that calcified arteries can make the ABI falsely high in people with diabetes, so record toe pressures or waveforms next to it where you have them. End with "PAD signs present" or "absent" for each foot.
5. Footwear and self-care
- Fit: the IWGDF practical guidelines say the inside of the shoe should be 1-2 cm longer than the foot and as wide as the foot at the metatarsophalangeal joints, with room for the toes. Check it standing.
- Type of shoe, wear patterns, any rubbing or pressure marks the shoe matches
- Socks, insoles or orthoses
- Barefoot walking at home
- Self-care: who checks their feet, nail care, knowledge of warning signs
6. Risk classification
Write the category and the system, for example "IWGDF risk 1 (low): LOPS, no PAD." Writing the reason with the category means a reader can check it against your findings, and it tells you what to look for next time.
The IWGDF 2023 categories are:
| IWGDF category | Characteristics | Screening frequency |
|---|---|---|
| 0, very low | No LOPS and no PAD | Once a year |
| 1, low | LOPS or PAD | Every 6-12 months |
| 2, moderate | LOPS + PAD, or LOPS + foot deformity, or PAD + foot deformity | Every 3-6 months |
| 3, high | LOPS or PAD, plus a history of foot ulcer, a lower-limb amputation or end-stage renal disease | Every 1-3 months |
The IWGDF notes that these intervals are expert opinion, not trial evidence.
7. Plan and next review
- Education given (and whether the person or a carer could repeat it back)
- Treatment done today: callus debridement, nail care, padding
- Footwear advice or a prescription
- Referrals: who to, why and how urgent
- Next review date, linked to the risk category
The review date is what turns a screen into a recall system, so put it in your calendar or recall list as well as the note.
How risk categories differ between guidelines
Use the system your health service or region has adopted, and name it in the note.
- ADA (US): the 2026 Standards use the IWGDF categories and intervals, call for a comprehensive foot evaluation at least once a year, and say people with sensory loss or a previous ulcer or amputation should have their feet inspected at every visit.
- Australia: the 2023 Australian guidelines on diabetes-related foot disease adapt the IWGDF system (very low, low, moderate and high) and use the same review intervals. Older local forms may still use the 2011 low, intermediate and high categories.
-
NICE (UK): NG19 uses its own categories:
- Low: no risk factors except callus alone. Review annually.
- Moderate: deformity, neuropathy or PAD. Review frequently, for example every 3-6 months.
- High: previous ulcer or amputation, renal replacement therapy, neuropathy plus PAD, or neuropathy or PAD with callus or deformity. Review more frequently, for example every 1-2 months, or every 1-2 weeks if there's immediate concern.
- Active diabetic foot problem: ulcer, infection, chronic limb-threatening ischemia, gangrene, suspected acute Charcot, or an unexplained hot, swollen foot with a change in color.
The same foot can land in different categories. Deformity with normal sensation and pulses is IWGDF risk 0 but NICE moderate risk. Neuropathy with callus is IWGDF risk 1 but NICE high risk. If your service uses NICE, write the NICE category, and add the IWGDF category if you report to a program that uses it.
Example note: low-risk foot
The details below are made up to show the format.
Diabetic foot screen, annual. Type 2 diabetes, 6 years.
History: No previous ulcer or amputation. No kidney disease. No vascular surgery. Never smoked. No numbness, pain or claudication. Checks own feet; good vision and mobility.
Inspection: Both feet: skin intact, normal color and temperature, no edema. Mild dry skin at both heels. No callus, no pre-ulcerative lesions. Nails well kept. No deformity. Joint mobility normal.
Sensation: 10 g monofilament, plantar hallux and 1st and 5th MTH: 3/3 at all sites, both feet. 128 Hz tuning fork at hallux: 3/3 both feet. LOPS absent bilaterally.
Vascular: DP and PT pulses palpable bilaterally. PAD signs absent.
Footwear: Lace-up walking shoes, good length and width, no pressure marks.
Risk: IWGDF risk 0 (very low): no LOPS, no PAD.
Plan: Discussed daily foot checks and moisturizing the heels (not between toes). Next screen in 12 months, due [date].
Example note: high-risk foot
Diabetic foot review. Type 2 diabetes, 18 years. Known peripheral neuropathy.
History: Plantar ulcer, R 1st MTH, healed [date]. No amputation. eGFR stable, not on dialysis. Ex-smoker. Numbness both feet, no claudication. Lives alone, daughter visits daily; can't reach feet easily.
Inspection: R: moderate callus under 1st MTH at site of previous ulcer, small area of hemorrhage within callus, no open wound. Clawed toes 2-4. L: light callus under 2nd MTH, clawed toes 2-3. Skin warm, no edema, no signs of infection. Limited R 1st MTPJ dorsiflexion.
Sensation: 10 g monofilament, plantar hallux and 1st and 5th MTH: 0/3 at all sites, both feet. 128 Hz tuning fork: not felt at hallux, felt at medial malleolus bilaterally. LOPS present bilaterally.
Vascular: DP and PT palpable bilaterally. No PAD signs.
Footwear: Wearing slip-on shoes, shallow toe box, rubbing over R 3rd toe. Custom insoles at home, not worn.
Risk: IWGDF risk 3 (high): LOPS plus previous ulcer. (NICE: high risk.)
Plan: Callus debrided R 1st MTH (hemorrhage photographed before debridement); skin intact beneath, no ulcer. Footwear advice given, insoles to be worn daily. Daughter to check feet daily; warning signs discussed with both. Referred for therapeutic footwear review. Next review in 4 weeks, due [date]. Person told to call the clinic the same day for any break in the skin, swelling, redness or warmth.
Diabetic foot exam template
Copy this into your notes system and change the sites, tests and risk system to match your service.
DIABETIC FOOT EXAM
Date: Clinician:
Diabetes type/duration: Last foot screen:
HISTORY
Previous ulcer (site/date): Previous amputation (level/side):
End-stage renal disease / dialysis: Y / N Charcot foot: Y / N
Vascular surgery/angioplasty: Y / N Retinopathy: Y / N Smoking: current / ex / never
Symptoms (numbness, pain, claudication):
Self-care limits (vision, reach, mobility, lives alone):
INSPECTION LEFT RIGHT
Skin (color, temp, edema):
Callus (site/severity):
Pre-ulcerative signs:
Ulcer (site/size/grade):
Nails:
Deformity:
Joint mobility:
SENSATION LEFT RIGHT
Monofilament 10 g, sites:
Site 1 (x/3):
Site 2 (x/3):
Site 3 (x/3):
Vibration 128 Hz (site felt):
Other test (Ipswich / pinprick / temperature):
LOPS: present/absent present/absent
VASCULAR LEFT RIGHT
Dorsalis pedis:
Posterior tibial:
ABI / toe pressure / TBI:
PAD signs: present/absent present/absent
FOOTWEAR AND SELF-CARE
Shoes (type/fit/wear):
Insoles/orthoses:
Barefoot at home: Y / N Who checks feet:
RISK CATEGORY
System used (IWGDF / NICE / other):
Category and reason:
PLAN
Education given:
Treatment today:
Referrals (to/reason/urgency):
Next review due:
Setting it up as a reusable note
If you screen often, a structured note saves typing and makes the records consistent between clinicians. In Caspen's progress notes you can build this exam as your own template, with dropdowns for pulses and the risk category, a table for left and right monofilament results, and a foot body chart for marking callus and lesions. Notes save as you go, you can add addenda to published notes, and you can export a PDF to send with a referral.
To keep the next review from being missed, book it before the person leaves, or run a report of clients without an upcoming appointment. There's more on how Caspen supports foot clinics on the podiatry page.
Sources
- IWGDF, Guidelines on the prevention of foot ulcers in persons with diabetes (2023) and Practical guidelines (2023)
- American Diabetes Association, Retinopathy, Neuropathy, and Foot Care: Standards of Care in Diabetes—2026
- NICE, Diabetic foot problems: prevention and management (NG19), recommendations
- Medical Journal of Australia, Australian evidence-based guidelines for the prevention and management of diabetes-related foot disease (2023)
These guidelines are updated regularly (the ADA revises its Standards every year, and the IWGDF plans its next update for 2027), so check the current version before you change your forms.
Ready to set up your own foot exam template? Start your free Caspen trial.